Elisa Lazzaroni

1.1k total citations · 1 hit paper
17 papers, 749 citations indexed

About

Elisa Lazzaroni is a scholar working on Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Clinical Psychology. According to data from OpenAlex, Elisa Lazzaroni has authored 17 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Pathology and Forensic Medicine and 3 papers in Clinical Psychology. Recurrent topics in Elisa Lazzaroni's work include Ophthalmology and Eye Disorders (7 papers), Pituitary Gland Disorders and Treatments (5 papers) and Diabetes Treatment and Management (4 papers). Elisa Lazzaroni is often cited by papers focused on Ophthalmology and Eye Disorders (7 papers), Pituitary Gland Disorders and Treatments (5 papers) and Diabetes Treatment and Management (4 papers). Elisa Lazzaroni collaborates with scholars based in Italy, United States and United Kingdom. Elisa Lazzaroni's co-authors include Ida Pastore, Paolo Fiorina, Maria Elena Lunati, Laura Montefusco, Francesca D’Addio, Moufida Ben Nasr, Cesare Berra, Gianvincenzo Zuccotti, Cristian Loretelli and Danila Covelli and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Frontiers in Psychology and Journal of the Neurological Sciences.

In The Last Decade

Elisa Lazzaroni

15 papers receiving 740 citations

Hit Papers

The anti-inflammatory and immunological properties of GLP... 2022 2026 2023 2024 2022 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists
    2022 217 citations Giulia Bendotti, Laura Montefusco et al. Pharmacological Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Lazzaroni Italy 10 440 167 144 115 113 17 749
Antoine Caillon Canada 14 139 0.3× 96 0.6× 28 0.2× 153 1.3× 80 0.7× 24 867
Alessandro Rossini Italy 11 249 0.6× 90 0.5× 24 0.2× 54 0.5× 118 1.0× 28 521
Yuji Tatara Japan 15 260 0.6× 95 0.6× 35 0.2× 170 1.5× 32 0.3× 23 983
Abdallah Al‐Salameh France 11 159 0.4× 95 0.6× 24 0.2× 124 1.1× 131 1.2× 39 608
Anel Gómez‐García Mexico 12 76 0.2× 58 0.3× 61 0.4× 75 0.7× 65 0.6× 44 458
Antônio Ribeiro‐Oliveira Brazil 16 514 1.2× 19 0.1× 46 0.3× 167 1.5× 38 0.3× 59 898
Christine M. Cunningham United States 9 145 0.3× 32 0.2× 68 0.5× 136 1.2× 16 0.1× 13 809
John Risvanis Australia 16 391 0.9× 191 1.1× 15 0.1× 271 2.4× 66 0.6× 27 1.2k
J. Mo United States 6 272 0.6× 14 0.1× 79 0.5× 90 0.8× 44 0.4× 12 654
Laura A. Bienvenu Australia 10 234 0.5× 119 0.7× 14 0.1× 122 1.1× 68 0.6× 14 587

Countries citing papers authored by Elisa Lazzaroni

Since Specialization
Citations

This map shows the geographic impact of Elisa Lazzaroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Lazzaroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Lazzaroni more than expected).

Fields of papers citing papers by Elisa Lazzaroni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Lazzaroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Lazzaroni. The network helps show where Elisa Lazzaroni may publish in the future.

Co-authorship network of co-authors of Elisa Lazzaroni

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Lazzaroni. A scholar is included among the top collaborators of Elisa Lazzaroni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Lazzaroni. Elisa Lazzaroni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lunati, Maria Elena, Davide Paolo Bernasconi, Olga Disoteo, et al.. (2026). The use of semaglutide as an add-on therapy in patients with latent autoimmune diabetes in adults. The Journal of Clinical Endocrinology & Metabolism.
2.
Bendotti, Giulia, Laura Montefusco, Ida Pastore, et al.. (2023). The anti-inflammatory and immunological properties of SGLT-2 inhibitors. Journal of Endocrinological Investigation. 46(12). 2445–2452. 24 indexed citations
3.
Bendotti, Giulia, Laura Montefusco, Maria Elena Lunati, et al.. (2022). The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists. Pharmacological Research. 182. 106320–106320. 217 indexed citations breakdown →
4.
Campi, Irene, Guia Vannucchi, Ilaria Muller, et al.. (2022). Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy. Frontiers in Endocrinology. 12. 790246–790246. 12 indexed citations
5.
6.
Lazzaroni, Elisa, Paola Basilico, Angelo Aliprandi, et al.. (2022). Monitoring cognitive and psychological alterations in COVID-19 patients: A longitudinal neuropsychological study. Journal of the Neurological Sciences. 444. 120511–120511. 23 indexed citations
7.
8.
Lazzaroni, Elisa, Moufida Ben Nasr, Cristian Loretelli, et al.. (2021). Anti-diabetic drugs and weight loss in patients with type 2 diabetes. Pharmacological Research. 171. 105782–105782. 115 indexed citations
9.
10.
Campi, Irene, Nicola Currò, Guia Vannucchi, et al.. (2020). Quantification of Global Ocular Motility Impairment in Graves' Orbitopathy by Measuring Eye Muscle Ductions. Thyroid. 31(2). 280–287. 7 indexed citations
11.
Vannucchi, Guia, Irene Campi, Danila Covelli, et al.. (2020). Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy. Thyroid. 31(5). 821–828. 36 indexed citations
12.
Lanzolla, Giulia, Guia Vannucchi, Ilaria Ionni, et al.. (2020). Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy. Frontiers in Endocrinology. 10. 933–933. 37 indexed citations
13.
Muller, Ilaria, Davide Dazzi, Danila Covelli, et al.. (2020). SARS-CoV-2-related atypical thyroiditis. The Lancet Diabetes & Endocrinology. 8(9). 739–741. 228 indexed citations
14.
15.
16.
Lazzaroni, Elisa, et al.. (2012). I contenuti tipici dei sogni. Una ricerca su sogni e narrative diurne di adolescenti e giovani adulti.. CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche). 11(2). 113–124. 2 indexed citations
17.
Barcellini, Wilma, et al.. (1988). Study on the interference of ticlopidine on the immune system.. PubMed. 10(3). 183–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antoine Caillon Breakdown of academic impact, for papers by Alessandro Rossini Breakdown of academic impact, for papers by Yuji Tatara Breakdown of academic impact, for papers by Abdallah Al‐Salameh Breakdown of academic impact, for papers by Anel Gómez‐García Breakdown of academic impact, for papers by Antônio Ribeiro‐Oliveira Breakdown of academic impact, for papers by Christine M. Cunningham Breakdown of academic impact, for papers by John Risvanis Breakdown of academic impact, for papers by J. Mo Breakdown of academic impact, for papers by Laura A. Bienvenu
Rankless by CCL
2026